This Article Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Hutton, J. Articles by Luce, B. R. Search for Related Content PubMed PubMed Citation Articles by Hutton, J. Articles by Luce, B. R. Related Collections Health Reform International Issues Pharmaceuticals Research And Technology

Health Affairs, Vol 13, Issue 3, 98-111
Copyright © 1994 by Project HOPE

Journal Article

The pharmaceutical industry and health reform: lessons from Europe

Many countries in Europe, which have significant pharmaceutical industries, recently have embarked on reforms in the organization of their health care systems and methods of regulating the pharmaceutical market. This paper describes the different systems in major European countries and the changes taking place. Although it is too early to make final judgment on the impact of these changes, it is possible to predict some of the more likely outcomes. The organizational models and regulatory approaches in Europe offer a useful store of experience for those assessing the potential impact of reform proposals in the United States.

                      What's this?

This article has been cited by other articles:

				N. Freemantle, D. Henry, A. Maynard, and G. Torrance Promoting cost effective prescribing BMJ, April 15, 1995; 310(6985): 955 - 956. [Full Text]